Full metadata record

DC Field Value Language
dc.contributor.authorBae, J-S.-
dc.contributor.authorLee, W.-
dc.contributor.authorSon, H-N.-
dc.contributor.authorLee, Y-M.-
dc.contributor.authorKim, I-S.-
dc.date.accessioned2024-01-20T08:30:38Z-
dc.date.available2024-01-20T08:30:38Z-
dc.date.created2021-09-02-
dc.date.issued2014-12-
dc.identifier.issn1748-1708-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/126074-
dc.description.abstractAimSepsis is a systemic inflammatory response syndrome resulting from a microbial infection. Transforming growth factor -induced protein (TGFBIp) is an extracellular matrix protein expressed by human endothelial cells and platelets that induces sepsis through interaction with integrin v5. The aim of this study was to investigate the role of TGFBIp in vascular permeability and the underlying mechanisms using TGFBIp-neutralizing antibody. MethodsMice were subjected to caecal ligation and puncture (CLP) with or without neutralizing anti-TGFBIp antibody (300gkg(-1), intravenously). Wild-type or integrin 5-null mice received TGFBIp (0.1mgkg(-1), intravenously) or were subjected to CLP. Human umbilical vein endothelial cells were exposed to lipopolysaccharide (100ngmL(-1)) with or without neutralizing anti-TGFBIp antibody (50gmL(-1)). ResultsAdministration of neutralizing anti-TGFBIp antibody in mice attenuated CLP-induced secretion of TGFBIp, leucocyte migration and vascular permeability and reduced septic mortality. Injected TGFBIp did not enhance vascular barrier permeability or leucocyte migration in 5-null mice. Finally, neutralizing anti-TGFBIp antibody inhibited the specific interactions between TGFBIp and its receptor, integrin v5. ConclusionOur findings demonstrate that treatment with a TGFBIp-neutralizing antibody can ameliorate the deleterious effects of sepsis.-
dc.languageEnglish-
dc.publisherWILEY-BLACKWELL-
dc.subjectLEUKOCYTE-ENDOTHELIAL INTERACTIONS-
dc.subjectNECROSIS-FACTOR-ALPHA-
dc.subjectINTEGRIN ALPHA-V-BETA-5-
dc.subjectINFLAMMATORY RESPONSES-
dc.subjectCELL-ADHESION-
dc.subjectANIMAL-MODELS-
dc.subjectWHOLE-BLOOD-
dc.subjectTGF-BETA-
dc.subjectBETA-IG-H3-
dc.subjectPERMEABILITY-
dc.titleAnti-transforming growth factor beta-induced protein antibody ameliorates vascular barrier dysfunction and improves survival in sepsis-
dc.typeArticle-
dc.identifier.doi10.1111/apha.12398-
dc.description.journalClass1-
dc.identifier.bibliographicCitationACTA PHYSIOLOGICA, v.212, no.4, pp.306 - 315-
dc.citation.titleACTA PHYSIOLOGICA-
dc.citation.volume212-
dc.citation.number4-
dc.citation.startPage306-
dc.citation.endPage315-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000345036800005-
dc.identifier.scopusid2-s2.0-84920437064-
dc.relation.journalWebOfScienceCategoryPhysiology-
dc.relation.journalResearchAreaPhysiology-
dc.type.docTypeArticle-
dc.subject.keywordPlusLEUKOCYTE-ENDOTHELIAL INTERACTIONS-
dc.subject.keywordPlusNECROSIS-FACTOR-ALPHA-
dc.subject.keywordPlusINTEGRIN ALPHA-V-BETA-5-
dc.subject.keywordPlusINFLAMMATORY RESPONSES-
dc.subject.keywordPlusCELL-ADHESION-
dc.subject.keywordPlusANIMAL-MODELS-
dc.subject.keywordPlusWHOLE-BLOOD-
dc.subject.keywordPlusTGF-BETA-
dc.subject.keywordPlusBETA-IG-H3-
dc.subject.keywordPlusPERMEABILITY-
dc.subject.keywordAuthorcaecal ligation and puncture-
dc.subject.keywordAuthorleucocyte migration-
dc.subject.keywordAuthorneutralizing antibody-
dc.subject.keywordAuthorsepsis-
dc.subject.keywordAuthortransforming growth factor -induced protein-
dc.subject.keywordAuthorvascular permeability-
Appears in Collections:
KIST Article > 2014
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE